Senior Manager, Medical Writing
Gilead SciencesSalary not specified
- Full Time
- Senior (5 to 8 years)
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Genomics, Medical ResearchIndustries
Requirements
Candidates must possess a Ph.D. or M.S. in life sciences with experience in a scientific/medical communications role, demonstrating a deep understanding of clinical genomics for screening and diagnostics. Previous experience in research publications in medical affairs within a clinical genomics organization is required, along with knowledge and familiarity with genomic NGS data. Strong team skills, written and oral communication skills, and excellent grammatical and editorial skills are essential.
Responsibilities
The Senior Medical Communications Specialist will work with cross-functional teams to plan, write, and edit publications and other collateral, leading the development of manuscripts for peer-reviewed research spanning diverse clinical areas. They will organize and develop strong manuscripts stemming from clinical research, research related to pharma companion diagnostics, and research to demonstrate the clinical validity and utility of ‘omics technologies. The role involves preparing scientific abstracts, posters, and presentations for conferences, supporting Illumina’s clinical data analysis team, and providing cross-functional support to various teams within the company. Additionally, they will propose improvements to authoring tools and drive projects to improve efficiency and sensible cost avoidance.
Skills
Scientific writing
Editing
Peer-reviewed publications
Medical communications
Clinical research
Genomics
Oncology
Hereditary disease
Reproductive genetics
Rare disease
Population screening
Infectious disease
DNA sequencing technology
Multi-omics
Cross-functional collaboration
Illumina
Supports genomics startups through funding and resources
About Illumina
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.
Key Metrics
San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees